№ lp_2_3_43821
File format: docx
Character count: 10064
File size: 63 KB
Year:
2027
Region / City:
United States
Theme:
Clinical Research, Institutional Review Boards
Document Type:
Agreement
Organization / Institution:
National Cancer Institute (NCI)
Author:
National Cancer Institute (NCI)
Target Audience:
Institutions involved in clinical trials
Period of Action:
Ongoing until the expiration of agreement
Approval Date:
N/A
Date of Changes:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
Boston, MA
Subject:
Clinical Trials, Consent Forms
Document Type:
Consent Form Template
Institution:
Dana-Farber/Harvard Cancer Center (DF/HCC)
Author:
DF/HCC Research Team
Target Audience:
Researchers, Study Coordinators, Institutional Review Boards
Effective Period:
Ongoing
Approval Date:
2026
Revision Date:
Not specified
Year:
2018
Region / City:
Dana-Farber/Harvard Cancer Center
Topic:
Research Consent Forms
Document Type:
Institutional Consent Language
Organization / Institution:
Dana-Farber/Harvard Cancer Center (DF/HCC)
Author:
N/A
Target Audience:
Research participants and their legal representatives
Effective Period:
N/A
Approval Date:
10.04.2018
Date of Changes:
N/A
Year:
2020
Region / City:
United States
Subject:
NCI CIRB process for research protocol approval
Document Type:
Instructional Guide
Author:
NCI CIRB
Target Audience:
Investigators, research staff, and affiliated personnel
Period of Validity:
N/A
Approval Date:
2020
Date of Last Revision:
2020
Year:
2021
Region / City:
Wisconsin
Topic:
Informed Consent Form Template
Document Type:
Template
Organization / Institution:
Medical College of Wisconsin
Author:
NCI CIRB
Target Audience:
Researchers, Institutional Review Boards
Period of Validity:
Ongoing
Approval Date:
N/A
Modification Date:
N/A
Year:
2019
Region / City:
United States
Topic:
Clinical Trials, Institutional Review Boards
Document Type:
Policy
Organization / Institution:
National Cancer Institute (NCI)
Author:
NCI
Target Audience:
NCTN and NCORP Sites, Clinical Trial Sites
Effective Period:
From March 1, 2019
Approval Date:
March 1, 2019
Modification Date:
Not specified
Year:
2023
Region / City:
United States
Subject:
Clinical Trial Studies, Institutional Review Board (IRB)
Document Type:
Authorization Agreement, Confidentiality Statement
Organization / Institution:
National Cancer Institute (NCI), CIRB
Author:
National Cancer Institute
Target Audience:
Institutions participating in clinical trials
Effective Period:
Until March 31, 2026
Approval Date:
Not specified
Amendment Date:
Not specified
Note:
Year
Topic:
Wastewater e-Service Signatory Agreement
Document Type:
Electronic Signature User Agreement
Agency:
Minnesota Pollution Control Agency (MPCA)
Target Audience:
Facility representatives, responsible officials, and e-service signatories
Year:
2023
Region / City:
Minnesota
Theme:
Air Quality, Environmental Protection
Document Type:
Permit Application
Organization / Institution:
Minnesota Pollution Control Agency (MPCA)
Author:
Minnesota Pollution Control Agency (MPCA)
Target Audience:
Facility operators, Responsible Officials, and designated Signatories
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Year
Document Type:
Electronic Signature User Agreement
Description:
Agreement form for authorizing and identifying a signatory for submitting industrial stormwater documents electronically to the MPCA.
Effective date:
1 August 2006
Document type:
Administrative mandate
Sector:
General Ophthalmic Services
Regulatory framework:
GOS Terms of Service
Subject:
Authorised signatories for GOS1 forms
Jurisdiction:
United Kingdom
Signatory requirements:
Practitioner and Contractor signatures under specified circumstances
Scope:
Financial and regulatory responsibilities for GOS claims
Supersedes:
All previous practice mandates
Change procedure:
New mandate required for any change in signatories
Year:
N/A
Region / City:
N/A
Topic:
Vehicle procurement and fleet management
Document Type:
Process document
Institution / Organization:
Office of Vehicle Management
Author:
N/A
Target Audience:
Agency fleet managers, vehicle procurement staff
Period of Validity:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2023
Region / City:
Sandia National Laboratories
Subject:
Certified payroll submission
Document Type:
Form
Organization:
Sandia National Laboratories
Author:
Not specified
Target Audience:
Company officials responsible for certified payroll submission
Effective Period:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
Not specified
Organization:
CVS Laboratory
Document Type:
Risk Assessment Record
Audience:
Laboratory staff and supervisors
Relevant Regulations:
Genetic modification and biological agent safety protocols
Review Frequency:
Annual
Sections Included:
RA1, Safe System of Work, Annexe A
Signatories:
User, Principal Investigator
Amendments:
Add new RAs as required and record reference numbers
Year:
2018
Jurisdiction:
New Zealand
Subject:
Land registration and legal declarations
Document type:
Statutory declaration form
Regulation:
Land Transfer Regulations 2018, Regulation 13(4)(a)
Author:
Declarant (name and details to be inserted)
Required identification:
Government-issued photographic ID
Related property:
Address or property linked to the instrument
Legal framework:
Oaths and Declarations Act 1957
Filing:
Lodged for registration with specified instrument number
Purpose:
Verification of signature and authority to register the instrument
Audience:
Legal and administrative authorities
Year:
2023
Region / City:
United States
Subject:
Clinical Trial Studies, Institutional Review Board (IRB)
Document Type:
Authorization Agreement, Confidentiality Statement
Organization / Institution:
National Cancer Institute (NCI), CIRB
Author:
National Cancer Institute
Target Audience:
Institutions participating in clinical trials
Effective Period:
Until March 31, 2026
Approval Date:
Not specified
Amendment Date:
Not specified
Note:
Year
Region / City:
St. Paul, MN
Subject:
Industrial Wastewater Discharge Authorization
Document Type:
Authorization Form
Issuing Organization:
Metropolitan Council Environmental Services
Target Audience:
Authorized Signatory
Year:
2015
Region / State:
Wisconsin
Country:
United States
Document Type:
Administrative form
Agency:
Wisconsin Department of Transportation (WisDOT)
Form Number:
DT1789
System:
WisDOT Transit Grants Management System
Purpose:
Request designation of signatory authority for a user within the Transit Grants Management System
User Information Fields:
Organization name, address, user name, title, phone, email, user status
Authorization Sections:
User agreement and organization authorization
Submission Method:
Email or postal mail
Contact Person:
Sarah Probasco
Institution Address:
4802 Sheboygan Ave, Room 951, Madison, WI 53705
Contact Email:
[email protected]
Internal Processing Section:
WisDOT approver signature, approver name, title, and approval date
Note:
Year
Topic:
Investment, Climate Change, Net Zero
Document Type:
Commitment Form
Organization / Institution:
AIGCC, Ceres, IGCC, IIGCC
Author:
Paris Aligned Investment Initiative
Target Audience:
Asset Owners, Investors
Period of Validity:
Until 2050
Year:
2023
Region / City:
United States
Subject:
Cancer Care Delivery, Oncology Research
Document Type:
Submission Worksheet
Organization / Institution:
National Cancer Institute (NCI)
Author:
NCI Protocol Information Office
Target Audience:
Researchers, Investigators, Study Coordinators
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / City:
Boston, MA
Subject:
Clinical Trials, Consent Forms
Document Type:
Consent Form Template
Institution:
Dana-Farber/Harvard Cancer Center (DF/HCC)
Author:
DF/HCC Research Team
Target Audience:
Researchers, Study Coordinators, Institutional Review Boards
Effective Period:
Ongoing
Approval Date:
2026
Revision Date:
Not specified